Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRAS<sup>G12D</sup> mutated pancreatic cancer in vivo model.

Panebianco, Concetta; Pisati, Federica; Villani, Annacandida; Andolfo, Annapaola; Ulaszewska, Marynka; Bellini, Edoardo; Ferro, Carmelapia; Lombardi, Renato; Orsenigo, Fabrizio; Latiano, Tiziana Pia; Belmonte, Beatrice; Tripodo, Claudio; Perri, Francesco; Pazienza, Valerio

Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRAS^G12D mutated pancreatic cancer in vivo model.

Panebianco, Concetta; Pisati, Federica; Villani, Annacandida; Andolfo, Annapaola; Ulaszewska, Marynka; Bellini, Edoardo; Ferro, Carmelapia; Lombardi, Renato; Orsenigo, Fabrizio; Latiano, Tiziana Pia; Belmonte, Beatrice; Tripodo, Claudio; Perri, Francesco; Pazienza, Valerio.

Afiliación

Panebianco C; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy.
Pisati F; Histopathology Unit, Cogentech S.C.a.R.L, FIRC Institute of Molecular Oncology (IFOM), Via Adamello, 16, 20139, Milan, MI, Italy.
Villani A; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy.
Andolfo A; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
Ulaszewska M; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
Bellini E; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
Ferro C; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy.
Lombardi R; Unit of Pharmacy, Department of Pharmaceuticals, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Orsenigo F; IFOM, FIRC Institute of Molecular Oncology, Milan, Italy.
Latiano TP; Oncology Unit Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy.
Belmonte B; Tumor Immunology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Via del Vespro 129, 90127, Palermo, Italy.
Tripodo C; Histopathology Unit, Cogentech S.C.a.R.L, FIRC Institute of Molecular Oncology (IFOM), Via Adamello, 16, 20139, Milan, MI, Italy.
Perri F; Tumor Immunology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Via del Vespro 129, 90127, Palermo, Italy.
Pazienza V; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy.

Cell Death Discov ; 9(1): 116, 2023 Apr 05.

Article en En | MEDLINE | ID: mdl-37019893

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Death Discov Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google